(XC) WisdomTree Emerging Markets - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717Y5353

XC: Emerging, Market, Stocks, Excluding, China

The WisdomTree Emerging Markets ex-China Fund (NYSE ARCA:XC) is an exchange-traded fund (ETF) that tracks a modified float-adjusted market cap weighted index, focusing on common stocks from emerging markets, excluding companies incorporated or domiciled in China. This strategic exclusion allows the fund to capitalize on growth opportunities in emerging economies outside of China, potentially reducing exposure to specific geopolitical and economic risks associated with Chinese companies.

By investing at least 80% of its total assets in component securities of the index and similar investments, the fund aims to replicate the indexs performance. The non-diversified nature of the index means it may be more susceptible to volatility due to its concentration in specific stocks or sectors, but it also allows for a more focused investment approach in emerging markets outside of China.

Analyzing the , the funds last price is $32.55, indicating a recent upward trend as it is above both its 20-day Simple Moving Average (SMA20) of $31.13 and its 50-day SMA of $30.16. The 200-day SMA stands at $31.28, suggesting a longer-term uptrend as the current price is above this level. The Average True Range (ATR) of 0.58, or 1.79%, indicates moderate volatility. Given these technical indicators, the trend appears bullish, with potential for further growth if the price maintains its position above these moving averages.

From a perspective, the funds Assets Under Management (AUM) stand at $80.96M USD, indicating a relatively modest size. While this could impact liquidity, it also suggests potential for growth as the fund is not overly large, possibly allowing for more agile investment strategies.

Forecasting the funds performance, considering both and , we can infer that if the current uptrend continues and the fund maintains its position above key moving averages, there may be potential for further price appreciation. The exclusion of Chinese companies could attract investors seeking emerging market exposure without the geopolitical risks associated with China. However, the funds non-diversified nature and the inherent volatility of emerging markets necessitate cautious monitoring of the funds performance and adjustments to investment strategies as needed.

Given the 52-week high of $33.94 and low of $26.82, the current price of $32.55 is near the upper end of this range, suggesting that while there may be potential for further growth, the fund is relatively close to its recent peak. Investors should be aware of potential resistance at this level and consider the overall market conditions and emerging markets trends before making investment decisions.

Additional Sources for XC ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

XC ETF Overview

Market Cap in USD 87m
Category Diversified Emerging Mkts
TER 0.32%
IPO / Inception 2022-09-20

XC ETF Ratings

Growth Rating 39.5
Fundamental -
Dividend Rating 36.4
Rel. Strength -5.08
Analysts -
Fair Price Momentum 31.87 USD
Fair Price DCF -

XC Dividends

Dividend Yield 12m 1.06%
Yield on Cost 5y 1.48%
Annual Growth 5y 48.21%
Payout Consistency 100.0%
Payout Ratio %

XC Growth Ratios

Growth Correlation 3m 95.4%
Growth Correlation 12m -25.8%
Growth Correlation 5y 88.9%
CAGR 5y 14.77%
CAGR/Max DD 5y 0.70
Sharpe Ratio 12m 0.87
Alpha -3.61
Beta 0.780
Volatility 16.92%
Current Volume 10.1k
Average Volume 20d 4.5k
What is the price of XC shares?
As of July 01, 2025, the stock is trading at USD 34.42 with a total of 10,098 shares traded.
Over the past week, the price has changed by +4.15%, over one month by +7.08%, over three months by +16.48% and over the past year by +8.88%.
Is WisdomTree Emerging Markets a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, WisdomTree Emerging Markets (NYSE ARCA:XC) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.51 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XC is around 31.87 USD . This means that XC is currently overvalued and has a potential downside of -7.41%.
Is XC a buy, sell or hold?
WisdomTree Emerging Markets has no consensus analysts rating.
What are the forecasts for XC share price target?
According to our own proprietary Forecast Model, XC WisdomTree Emerging Markets will be worth about 36.8 in July 2026. The stock is currently trading at 34.42. This means that the stock has a potential upside of +6.83%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 36.8 6.8%